bupranolol has been researched along with Endometrial Neoplasms in 1 studies
Bupranolol: An adrenergic-beta-2 antagonist that has been used for cardiac arrhythmia, angina pectoris, hypertension, glaucoma, and as an antithrombotic.
Endometrial Neoplasms: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our study indicates that ovarian cancer considerably alters contractile activity of the nonpregnant human uterus in response to ADRB antagonists." | 1.62 | Myometrial Responses to Beta-Adrenoceptor Antagonists in Gynecological Malignancies. ( Jóźwik, M; Kleszczewski, T; Modzelewska, B; Sulkowski, S, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Modzelewska, B | 1 |
| Jóźwik, M | 2 |
| Kleszczewski, T | 1 |
| Sulkowski, S | 1 |
1 other study available for bupranolol and Endometrial Neoplasms
| Article | Year |
|---|---|
Myometrial Responses to Beta-Adrenoceptor Antagonists in Gynecological Malignancies.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Bupranolol; Endometrial Neoplasms; Ethanolami | 2021 |